Patents by Inventor Gregory Whitten Peet

Gregory Whitten Peet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assays useful in determining CD38 inhibition
    Patent number: 7977043
    Abstract: An assay for use in high-throughput screening of chemical libraries to determine whether compounds in such libraries will inhibit CD38 catalytic activity, and CD38 production of ADPR and cADPR.
    Type: Grant
    Filed: November 10, 2006
    Date of Patent: July 12, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Susan Lukas, Gregory Whitten Peet, Brian Werneburg
  • METHODS FOR THE IDENTIFICATION OF IKKALFA FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20090186010
    Abstract: The invention provides a method for identifying genes involved in the NF-?B pathway comprised of the steps of determining the level of expression of a gene in an experimental sample obtained from the cells having deficient levels of a component of the NF-?B pathway; determining the level of expression of said gene in a control sample obtained from wild type cells having levels of a component of a biological pathway; selecting genes having a level of expression that are modulated in said experimental sample relative to said wild type sample. The invention also provides a method of treating inflammatory related diseases by modulating the activity of IKK?.
    Type: Application
    Filed: November 14, 2008
    Publication date: July 23, 2009
    Inventors: Jun Li, Adedayo Hanidu, Xiang Li, Gregory Whitten Peet, Sheenah Mische, Kenneth Marcu
  • ASSAYS USEFUL IN DETERMINING CD38 INHIBITION
    Publication number: 20080113871
    Abstract: An assay for use in high-throughput screening of chemical libraries to determine whether compounds in such libraries will inhibit CD38 catalytic activity, and CD38 production of ADPR and cADPR.
    Type: Application
    Filed: November 10, 2006
    Publication date: May 15, 2008
    Inventors: Susan Lukas, Gregory Whitten Peet, Brian Werneburg
  • Methods for the identification of IKKalpha function and other genes useful for treatment of imflammatory diseases
    Publication number: 20040014111
    Abstract: The invention provides a method for identifying genes involved in the NF-&kgr;B pathway comprised of the steps of determining the level of expression of a gene in an experimental sample obtained from the cells having deficient levels of a component of the NF-&kgr;B pathway; determining the level of expression of said gene in a control sample obtained from wild type cells having levels of a component of a biological pathway; selecting genes having a level of expression that are modulated in said experimental sample relative to said wild type sample. The invention also provides a method of treating inflammatory related diseases by modulating the activity of IKK&agr;.
    Type: Application
    Filed: May 23, 2003
    Publication date: January 22, 2004
    Inventors: Jun Li, Adedayo Hanidu, Xiang Li, Gregory Whitten Peet, Sheenah Mische, Kenneth Marcu